🎄🌟 🎉 Wishing our readers a Merry Christmas and a Happy New Year filled with new possibilities! 🎄🌟 🎉
MilliporeSigma advances next generation antibody-drug conjugate therapies
World | News | 0 Comment | 29 Oct, 2021
MilliporeSigma, the U.S. and Canadian Life Science business of Merck KGaA, Darmstadt, Germany, a leading science an...Read more
Waters & Sartorius join hands to enhance clone selection and process development
World | News | 0 Comment | 28 Oct, 2021
Waters Corporation and Sartorius have announced that they will partner to provide bioprocess experts with direct access ...Read more
EY launches technology-driven solution for life sciences industry
World | News | 0 Comment | 22 Oct, 2021
EY has announced the launch of EY Smart Reviewer, a new technology-driven solution for the life sciences industry. It le...Read more
QIAGEN launches novel tuberculosis test for high-burden regions
World | News | 0 Comment | 20 Oct, 2021
QIAGEN N.V. has announced the launch and CE marking of QIAreach® QuantiFERON®-TB test for tuberculosis (TB) infe...Read more
TB deaths increase first time in over a decade: WHO 2021 report
World | News | 0 Comment | 15 Oct, 2021
The COVID-19 pandemic has reversed years of global progress in tackling tuberculosis and for the first time in over a de...Read more
One-shot Sputnik Light vaccine demonstrates 70% efficacy against Delta variant
World | News | 0 Comment | 14 Oct, 2021
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and Gamaleya National Research Cent...Read more
Water pill may be viable to test as Alzheimer’s treatment: NIH study
World | News | 0 Comment | 13 Oct, 2021
A commonly available oral diuretic pill approved by the U.S. Food and Drug Administration (FDA) may be a potential candi...Read more
CEPI explores impact of small booster doses of COVID-19 vaccines
World | News | 0 Comment | 12 Oct, 2021
Norway-based Coalition for Epidemic Preparedness Innovations, or CEPI, has launched a new call for proposals to fund cli...Read more
Moderna to build state-of-the-art mRNA vaccine facility in Africa
World | News | 0 Comment | 08 Oct, 2021
American firm Moderna, Inc. will build a state-of-the-art mRNA facility in Africa with the goal of producing u...Read more
WHO recommends groundbreaking malaria vaccine for children
World | News | 0 Comment | 07 Oct, 2021
The World Health Organization (WHO) is recommending widespread use of the RTS,S/AS01 (RTS,S) malaria vaccine (Mosquirix)...Read more
Merck launches excipient technology platform for protein-based therapeutics
World | News | 0 Comment | 05 Oct, 2021
The Life Science business of Merck has launched a new Viscosity Reduction Excipient Platform to reduce the viscosity and...Read more
Thermo Fisher launches SpeciMAX stabilized saliva collection kit
World | News | 0 Comment | 29 Sep, 2021
Thermo Fisher Scientific has launched the Thermo Scientific SpeciMAX Stabilized Saliva Collection Kit, which is designed...Read more
Thermo Fisher Scientific Launch World’s First Net Zero Mass Spectrometer
World | News | 0 Comment | 23 Sep, 2021
The launch of the world’s first net zero mass spectrometer (MS) will make it easier than ever for scientists wor...Read more
Global Index enters to track pathogens around the world
World | News | 0 Comment | 22 Sep, 2021
The Future Investment Initiative (FII) Institute has launched the Global Infectious Diseases Index. It uses&nb...Read more
Waters introduces new integrated high-resolution LC-MS system
World | News | 0 Comment | 15 Sep, 2021
US-based Waters Corporation has introduced the Waters™ BioAccord™ System with ACQUITY™ Premier, a...Read more
Thermo Fisher expands global network of single-use technology
World | News | 0 Comment | 09 Sep, 2021
Thermo Fisher Scientific Inc. has announced plans to establish a manufacturing facility in Nashville, US ...Read more
Vax cocktail endgame against COVID-19
World | Opinion | 0 Comment | 06 Sep, 2021
Vaccine mixing, which began unintentionally, is now gaining traction. There is a significant interest in mixing two diff...Read more
Thermo Fisher, AstraZeneca to co-develop NGS-based companion diagnostics
World | News | 0 Comment | 03 Sep, 2021
Thermo Fisher Scientific's clinical sequencing business and AstraZeneca are co-developing next-generation sequencing (NG...Read more